Literature DB >> 31988686

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics.

Ali Agha1, Abdulrazzak Zarifa2, Peter Kim2, Cezar Iliescu2, Greg Gladish2, Saamir Hassan2, Nicolas Palaskas2, Jean B Durand2, Yang Lu2, Juan Lopez-Mattei2.   

Abstract

Innovations and discoveries in cancer therapeutics have improved survival rates in patients with various types of malignancies. At the same time, physicians are identifying an increased number of patients with treatment-related cardiotoxicity. It is imperative that physicians recognize early treatment-related adverse effects to determine the safest therapeutic options for patients with cancer. This manuscript evaluates the role of cardiovascular imaging and biomarkers in identifying cardiotoxicity trigged by various chemotherapeutic agents and summarizes expert consensus statements regarding cardiotoxicity monitoring.
© 2019 Houston Methodist Hospital Houston, Texas.

Entities:  

Keywords:  CMR; anthracyclines; biomarkers; cardiac magnetic resonance; cardiotoxicity; echocardiogram; immune checkpoint inhibitors

Mesh：

Substances：

Year:  2019        PMID： 31988686      PMCID： PMC6977565          DOI： 10.14797/mdcj-15-4-258

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  41 in total

1.  Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma.

Authors:  David J Casey; Alice Y Kim; Adam J Olszewski
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors.

Authors:  Nicolas Palaskas; Jacob Morgan; Tina Daigle; Jose Banchs; Jean-Bernard Durand; David Hong; Aung Naing; Hung Le; Saamir A Hassan; Kaveh Karimzad; Elie Mouhayar; Peter Kim; Juan Lopez-Mattei; Kara Thompson; Syed Wamique Yusuf; Cezar Iliescu
Journal:  Am J Cardiol       Date:  2019-01-25       Impact factor: 2.778

4.  Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.

Authors:  Michael S Ewer; Mary T Vooletich; Jean-Bernard Durand; Myrshia L Woods; Joseph R Davis; Vicente Valero; Daniel J Lenihan
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

5.  Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients.

Authors:  Y Edoute; N Haim; D Rinkevich; B Brenner; S A Reisner
Journal:  Am J Med       Date:  1997-03       Impact factor: 4.965

6.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Gaia De Giacomi; Mara Rubino; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

7.  Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.

Authors:  Milanthy S Pourier; Livia Kapusta; Aniek van Gennip; Jos P M Bökkerink; Jacqueline Loonen; Louise Bellersen; Annelies M C Mavinkurve-Groothuis
Journal:  Clin Chim Acta       Date:  2014-12-12       Impact factor: 3.786

8.  Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines.

Authors:  Mohammed T Ali; Evin Yucel; Souhila Bouras; Lin Wang; Hong-Wen Fei; Elkan F Halpern; Marielle Scherrer-Crosbie
Journal:  J Am Soc Echocardiogr       Date:  2016-04-08       Impact factor: 5.251

9.  Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.

Authors:  Tomas G Neilan; Otavio R Coelho-Filho; Diego Pena-Herrera; Ravi V Shah; Michael Jerosch-Herold; Sanjeev A Francis; Javid Moslehi; Raymond Y Kwong
Journal:  Am J Cardiol       Date:  2012-08-21       Impact factor: 2.778

10.  Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance.

Authors:  Hans Huang; Prabhjot S Nijjar; Jeffrey R Misialek; Anne Blaes; Nicholas P Derrico; Felipe Kazmirczak; Igor Klem; Afshin Farzaneh-Far; Chetan Shenoy
Journal:  J Cardiovasc Magn Reson       Date:  2017-03-24       Impact factor: 5.364
View more
  1 in total

1.  Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL.

Authors:  Jian Li; Hui Luo; Ying-Ying Liu; Li-Xin Chen; Mei-Qin Zhu; Quan-Tong Deng; Dong-Mei Zhu; Zi-Mo Wang; Jin-Feng Xu
Journal:  Pharmgenomics Pers Med       Date:  2022-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.